Jeong H. Ha
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.
Journal: Experimental neurobiology
Published: February 20, 2025
Integrating visual assessments and quantification methods for tau PET staging.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 04, 2025
Cutoff SUVR of [18F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction.
Journal: Nuclear medicine and molecular imaging
Published: November 20, 2024
Incidental 18F-Florapronol Uptake in Meningioma.
Journal: Clinical nuclear medicine
Published: March 04, 2021
The correlation of neuropsychological evaluation with 11C-PiB and 18F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease.
Journal: Medicine
Published: April 22, 2020
Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 23, 2019
Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system.
Journal: Science advances
Published: August 17, 2018
Head-to-head comparison of 18 F-FP-CIT and 123 I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study.
Journal: Synapse (New York, N.Y.)
Published: October 29, 2017
Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
Journal: Medicine
Published: March 23, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026